BMY vs LLY
Bristol Myers Squibb vs Eli Lilly and Company — AI-powered side-by-side comparison
| Metric | BMY | LLY |
|---|---|---|
| AI Score | 70 | 63 |
| Price | $57.56 | $1,188.57 |
| P/E Ratio | 19.93× | 45.52× |
| ROE | 41.6% | 101.3% |
| Revenue Growth YoY | 1.8% | 47.4% |
| Gross Margin | 53.7% | 82.8% |
| Debt / Equity | 2.44× | 1.60× |
| Dividend Yield | 4.3% | 0.6% |
| RSI (14) | 53.8 | 51.0 |
| Beta | 0.235 | 0.5022 |
| Expected Upside | +4.6% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
LLY Full Analysis